Integrin αvβ6 and MMP-9 in Colon Cancer
Author Information
Author(s): Gu X, Niu J, Dorahy D J, Scott R, Agrez M V
Primary Institution: Newcastle Bowel Cancer Research Collaborative, Hunter Medical Research Institute, John Hunter Hospital and The University of Newcastle, NSW 2308, Australia
Hypothesis
Inhibition of integrin αvβ6 expression in colon cancer cells suppresses MMP-9 secretion.
Conclusion
Targeting integrin αvβ6 or its interaction with ERK2 may provide a therapeutic approach to prevent colon cancer growth and spread.
Supporting Evidence
- Down-regulation of β6 expression significantly inhibits MMP-9 secretion in colon cancer cells.
- Transfection of cells with a β6 mutant lacking the ERK2 binding site reduces MMP-9 secretion.
- MEK-1 inhibitor treatment also markedly reduces MMP-9 secretion in β6-expressing cells.
Takeaway
This study found that blocking a specific protein in colon cancer cells can stop them from releasing a substance that helps tumors grow.
Methodology
The study involved transfecting colon cancer cell lines with antisense β6 and measuring MMP-9 secretion.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website